These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review. Grosso S; Cordelli DM; Coppola G; Franzoni E; Verrotti A; Berardi R; Balestri P Eur J Neurol; 2008 Sep; 15(9):940-6. PubMed ID: 18637038 [TBL] [Abstract][Full Text] [Related]
4. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience. Shah YD; Singh K; Friedman D; Devinsky O; Kothare SV Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692 [TBL] [Abstract][Full Text] [Related]
5. Felbamate in an adult population with severe refractory epilepsy. Kearney H; Delanty N Ir Med J; 2009; 102(10):326-8. PubMed ID: 20108801 [TBL] [Abstract][Full Text] [Related]
12. Neuropsychiatric side effects related to treatment with felbamate. McConnell H; Snyder PJ; Duffy JD; Weilburg J; Valeriano J; Brillman J; Cress K; Cavalier J J Neuropsychiatry Clin Neurosci; 1996; 8(3):341-6. PubMed ID: 8854308 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of felbamate in children with refractory epilepsy. Heyman E; Levin N; Lahat E; Epstein O; Gandelman-Marton R Eur J Paediatr Neurol; 2014 Nov; 18(6):658-62. PubMed ID: 24906615 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of felbamate in the treatment of intractable pediatric epilepsy. Zupanc ML; Roell Werner R; Schwabe MS; O'Connor SE; Marcuccilli CJ; Hecox KE; Chico MS; Eggener KA Pediatr Neurol; 2010 Jun; 42(6):396-403. PubMed ID: 20472190 [TBL] [Abstract][Full Text] [Related]
16. The rise and fall of felbamate as a treatment for partial epilepsy--aplastic anemia and hepatic failure to blame? Thakkar K; Billa G; Rane J; Chudasama H; Goswami S; Shah R Expert Rev Neurother; 2015; 15(12):1373-5. PubMed ID: 26566191 [TBL] [Abstract][Full Text] [Related]